男性不育症的内分泌治疗中国专家共识  

Chinese expert consensus on endocrine therapy of male infertility

作　　者：中国医师协会生殖医学专业委员会生殖男科学组男性不育症的内分泌治疗中国专家共识编写组 熊承良 谷翊群 康跃凡 陈向锋[2] 安庚 郭海彬[4] 刘贵华 陆金春 卢少明[7] 麦选诚[8] 马选 潘峰 杨险峰 尹太郎[11] 赵小东[12] Chinese Expert Consensus Compilation Group for Endocrine Therapy of Male Infertility,Reproductive Andrology Group,Reproductive Medicine Professional Committee of Chinese Medical Doctor Association;Xiong Chengliang;Gu Yiqun;Kang Yuefan

机构地区：[1]不详 [2]上海交通大学医学院附属仁济医院 [3]广州医科大学附属第三医院 [4]河南省人民医院 [5]中山大学附属第六医院 [6]东南大学附属中大医院 [7]山东大学生殖医院 [8]云南省第一人民医院 [9]华中科技大学同济医学院附属协和医院 [10]郑州大学第三附属医院 [11]武汉大学人民医院 [12]兰州大学第一医院

出　　处：《中华生殖与避孕杂志》2023年第3期235-245,共11页Chinese Journal of Reproduction and Contraception

基　　金：国家重点研发计划(2018YFC1004601);国家科技支撑计划(2012BAI32B03)。

摘　　要：内分泌因素是导致男性不育的重要原因之一,而内分泌治疗是改善男性生育能力的重要手段。本共识由中国医师协会生殖医学专业委员会生殖男科学组组织专家编写,从男性不育症的内分泌因素及分类、男性生殖内分泌的调控、常用的内分泌药物及相关制剂、常用的内分泌治疗方案以及内分泌治疗的展望等多个方面进行了深入的探讨。此外,针对男性不育症的不同病因或不同临床表现,本文提出了广泛认可的内分泌治疗策略。本共识的建立有助于规范男性不育症的内分泌治疗,为从事生殖男科的专业医务人员提供专家建议。Endocrine disorder is one of the important causes of male infertility,and endocrine therapy can help improve male fertility.This consensus was prepared by experts from the Reproductive Andrology Group of the Reproductive Medicine Special Committee of the Chinese Medical Association.Here,we discussed in depth the endocrine factors and classification of male infertility.We also discussed the regulation of male reproductive endocrine,commonly used endocrine drugs and related preparations,commonly used endocrine treatment schemes and the prospect of endocrine treatment.In addition,according to the different causes or clinical features of male infertility,this paper put forward widely recognized endocrine treatment schemes.The establishment of this consensus will help regulate the endocrine treatment of male infertility and provide expert advice for medical personnel engaged in reproductive medicine or andrology.

关 键 词：不育 男性 内分泌因素 内分泌治疗 生殖男科学 专家共识 

分 类 号：R698.2[医药卫生—泌尿科学]